Skip to content

Core Laboratories CLB Return on equity

Return on equity at other companies

Halliburton logo
HalliburtonHAL
14.6%-6.4pp
Schlumberger
 logo
Schlumberger SLB
14.6%-6.2pp
Baker Hughes logo
Baker HughesBKR
17.1%-0.9pp
Forum Energy Technologies logo
Forum Energy TechnologiesFET
-31.1%-72.4pp
RPC logo
RPCRES
2.2%-5.0pp
Weatherford International logo
Weatherford InternationalWFRD
29.8%-8.7pp

Other financials

Income statement

See full
Revenue$121.8M-1.4%
Operating income$1.9M-57.3%
Net income-$789.0K-412%
EPS (diluted)-$0.02

Balance sheet

See full
Cash & equivalents$22.8M+3.2%
Total debt$167.8M-6.8%
Total equity$268.9M+6.1%
Total assets$587.7M+0.3%

Cash flow

See full
Operating cash flow$4.0M-40.5%
CapEx$3.4M+23.8%
Free cash flow$517.0K-86.7%

Valuation

See full
Market cap$503.38M-13.5%
Enterprise value$648.4M-12.3%
P/E17.3×-3.4×
P/S-0.2×

Profitability

See full
Operating margin10.3%-0.2pp
Net margin5.5%+0.1pp
FCF margin4.3%-4.6pp

Returns & leverage

See full
Debt / equity0.6×-0.1×
Current ratio-0.2×

Where this comes from

Calculated from Core Laboratories’s reported figures.

Based on trailing twelve months.

The official record: Core Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Core Laboratories's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Core Laboratories's return on equity?
Core Laboratories (CLB) reported return on equity of 11.1% in Q1 2026.
How has Core Laboratories's return on equity changed year-over-year?
Core Laboratories's return on equity decreased by 3.7% year-over-year, from 11.5% to 11.1%.
What is the long-term trend for Core Laboratories's return on equity?
Over 2 years (2023 to 2025), Core Laboratories's return on equity has grown at a -19.6% compound annual growth rate (CAGR), from 17.9% to 11.6%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.